2m 2m 2m 2m 2m 2m 2m
ALX ONCOLOGY (ALXO)
NASDAQ
$2.04-$0.005 (-0.25%)
Price as of Aug 21, 2026 7:52 PM EDT- $282.1MMarket Cap
- 74.36%1-Year Change
- BiotechnologyIndustry
ALX ONCOLOGY (ALXO)
$2.04-$0.005 (-0.25%)
ALXO | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $2.04 | ||
Change | +$0.05 (+2.51%) | ||
Open | $2.01 | ||
High | $2.07 | ||
Low | $1.98 | ||
Previous Close | $1.99 | ||
Volume | 410,888 | ||
30-Day Average Volume | 1,033,878 | ||
1-Week Change | 4.08% | ||
1-Month Change | -0.49% | ||
1-Year Change | 74.36% | ||
3-Year Change | -57.23% | ||
5-Year Change | -96.74% | ||
Fundamentals | |||
Shares Outstanding | 138.3M | ||
Total Assets | $160.8M | ||
Market Cap | $282.1M | ||
Enterprise Value | $269.1M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$18.0M | ||
Free Cash Flow | -$16.1M | ||
EBIT | -$17.7M | ||
EBITDA | -$17.6M | ||
Net Working Capital | $128.7M | ||
EPS | -$0.13 | ||
Enterprise Value/EBITDA | -15 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 2 | ||
P/E | -16 | ||
PEG | -1 | ||
Price/Free Cash Flow | -18 | ||
Price/Operating Cash Flow | -18 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue